1Francisco AL, Pi? era C. Anemia Trials in CKD and Clinical Practice: Refining the Approach to Erythropoiesis - Stimulating Agents. Contrib Nephrol, 2011, 171:248 - 254.
3Kusano E, Yakushiji, Shimotsuke, Clin Exp Nephrol. 2011 Jun 1. [Epub ahead of print] Mechanism by which chronic kidney disease causes cardiovascular disease and themeasures to manage this phenomenon. PMID, 21629994.
4Handelman G J, Levin NW. Red cell survival: relevance and mechanism involved. J Ren Nutr,2010,20(5 ) :84 - 88.
3Movillie,Cancarinig C.Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatiple membranes in hemodialysis patients.Nephrol Dial Transplant,2001,16:111.
